Timmerman Report articles about the coronavirus pandemic are being made free for everyone. It’s a public health emergency. This in-depth reporting and fact-based analysis should be widely available, not just for biopharmaceutical professionals who are paying subscribers.
Timmerman Report is an independent subscription publication founded in 2015. It’s for anyone who seeks to understand new drug development, diagnostics, genomics, and technologies changing medicine.